Berkshire Hematology Oncology

Pittsfield, Massachusetts 01201-8298

0 studies enrolling now · 3 studies all time

What they study most

Hormone Refractory Prostate Cancer, Multiple Myeloma, Pancreatic Cancer, Prostate Cancer

Studies at this site

• Zoledronic Acid Treatment (Every 4 or 12 Weeks) to Prevent Skeletal Complications in Advanced Multiple Myeloma Participants — Completed
• Masitinib in Combination With Gemcitabine for Treatment of Patients With Advanced/Metastatic Pancreatic Cancer — Completed
• Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen — Completed